Addex Therapeutics Stock Price Patterns
| ADXN Stock | USD 7.54 0.23 2.96% |
Momentum 45
Impartial
Oversold | Overbought |
Wall Street Target Price 30 | Quarterly Revenue Growth (0.15) |
Using Addex Therapeutics hype-based prediction, you can estimate the value of Addex Therapeutics from the perspective of Addex Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Addex Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Addex because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Addex Therapeutics after-hype prediction price | USD 7.57 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Addex Therapeutics Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Addex Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Addex Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Addex Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Addex Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Addex Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Addex Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Addex Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Addex Therapeutics' historical news coverage. Addex Therapeutics' after-hype downside and upside margins for the prediction period are 2.59 and 12.55, respectively. We have considered Addex Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Addex Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Addex Therapeutics is based on 3 months time horizon.
Addex Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Addex Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Addex Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Addex Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.06 | 4.98 | 0.03 | 0.00 | 6 Events / Month | 4 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
7.54 | 7.57 | 0.40 |
|
Addex Therapeutics Hype Timeline
Addex Therapeutics is presently traded for 7.54. The entity has historical hype elasticity of 0.03, and average elasticity to hype of competition of 0.0. Addex is anticipated to increase in value after the next headline, with the price projected to jump to 7.57 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 0.4%, whereas the daily expected return is presently at -0.06%. The volatility of related hype on Addex Therapeutics is about 35571.43%, with the expected price after the next announcement by competition of 7.54. The company reported the previous year's revenue of 404.1 K. Net Income was 7.06 M with loss before overhead, payroll, taxes, and interest of (525.65 K). Given the investment horizon of 90 days the next anticipated press release will be in about 6 days. Check out Addex Therapeutics Basic Forecasting Models to cross-verify your projections.Addex Therapeutics Related Hype Analysis
Having access to credible news sources related to Addex Therapeutics' direct competition is more important than ever and may enhance your ability to predict Addex Therapeutics' future price movements. Getting to know how Addex Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Addex Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CDIO | Cardio Diagnostics Holdings | (0.36) | 6 per month | 0.00 | (0.17) | 14.54 | (13.93) | 38.04 | |
| BCLI | Brainstorm Cell Therapeutics | (0.02) | 5 per month | 0.00 | (0.04) | 9.09 | (6.78) | 24.01 | |
| MTNB | Matinas BioPharma Holdings | 0.1 | 5 per month | 0.00 | (0.11) | 11.67 | (10.45) | 37.19 | |
| RADX | Radiopharm Theranostics Limited | 0.00 | 0 per month | 7.35 | 0.06 | 7.44 | (7.58) | 193.18 | |
| IBO | Impact BioMedical | 0.02 | 6 per month | 0.00 | (0.02) | 8.00 | (7.41) | 61.57 | |
| QNRX | Quoin Pharmaceuticals Ltd | (0.92) | 12 per month | 8.39 | 0.03 | 18.69 | (10.99) | 77.47 | |
| TCRT | Alaunos Therapeutics | 0.04 | 6 per month | 5.64 | 0.03 | 10.07 | (10.55) | 24.31 | |
| NRSN | Neurosense Therapeutics | (0.02) | 10 per month | 4.49 | 0.04 | 12.82 | (7.37) | 34.62 | |
| NBY | NovaBay Pharmaceuticals | 1.28 | 7 per month | 15.98 | 0.05 | 33.70 | (29.80) | 158.53 | |
| ADIL | Adial Pharmaceuticals | (0.26) | 9 per month | 0.00 | (0.32) | 5.70 | (8.24) | 34.48 |
Addex Therapeutics Additional Predictive Modules
Most predictive techniques to examine Addex price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Addex using various technical indicators. When you analyze Addex charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Addex Therapeutics Predictive Indicators
The successful prediction of Addex Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Addex Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Addex Therapeutics based on analysis of Addex Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Addex Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Addex Therapeutics's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 34.23 | 13.81 | 15.88 | 15.09 | PTB Ratio | 2.98 | 0.58 | 0.52 | 0.5 |
Pair Trading with Addex Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.
The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Addex Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Will Biotechnology sector continue expanding? Could Addex diversify its offerings? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Addex Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (9.37) | Revenue Per Share | Quarterly Revenue Growth (0.15) | Return On Assets | Return On Equity |
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Addex Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Addex Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Addex Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.